ArticleNature communications2019
Open data on industry payments to healthcare providers reveal potential hidden costs to the public.
Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Medical Device Industry Payments and Utilization of Corresponding Devices.JAMA network open · 2026Article
- Surgical society committee members disclosure of conflict of interest: show me the money.Surgical endoscopy · 2026Article
- Article
- Article
- Trends in Industry Payments to Cardiologists From 2014 to 2019.Circulation. Cardiovascular quality and outcomes · 2023Article
- Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis.BMJ open · 2023Article
- Associations Between Industry Payments to Physicians for Antiplatelet Drugs and Utilization of Cardiac Procedures and Stents.Journal of general internal medicine · 2022Article
- Interaction between physicians and the pharmaceutical industry: A scoping review for developing a policy brief.Frontiers in public health · 2022Article
- Changes in industry marketing payments to physicians during the covid-19 pandemic: quasi experimental, difference-in-difference study.BMJ medicine · 2022Article
- Review
- In Reply to Halperin.International journal of radiation oncology, biology, physics · 2021Article
- Drug company payments to General Practices in England: Cross-sectional and social network analysis.PloS one · 2021Article
- Open Data: Implications on Privacy in Healthcare Research.Blockchain in healthcare today · 2020Review
- Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.BMJ (Clinical research ed.) · 2019Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Healthcare industry players make payments to medical providers for non-research expenses. While these payments may pose conflicts of interest, their relationship with overall healthcare costs remains largely unknown. In this study, we linked Open Payments data on providers' industry payments with Medicare data on healthcare costs. We investigated 374,766 providers' industry payments and healthcare costs. We demonstrate that providers receiving higher amounts of industry payments tend to bill higher drug and medical costs. Specifically, we find that a 10% increase in industry payments is associated with 1.3% higher medical and 1.8% higher drug costs. For a typical provider, for example, a 10% or $25 increase in annual industry payments would be associated with approximately $1,100 higher medical costs and $100 higher drug costs. Furthermore, the association between payments and healthcare costs varies markedly across states and correlates with political leaning, being stronger in more conservative states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.